JA
Insider
Jeffrey W. Albers
DirectorJeffrey W. Albers (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in BPMC. The largest single filing was $2.4M of SYRE (23,000 sh across 3 lots, as filed), executed Aug 7.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.1M
shares × price, as filed
Last traded
Aug 7
Filed Aug 10
Median ADV $118.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $9.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
BPMC
BPMC
BPMC · 0 buys · 7 sells
7 filings
KYMRRecent filings
SYRESALE
Spyre Therapeutics, Inc.
View filing →
$2.4M23,000 sh across 3 lots
Exec Aug 7
Filed Aug 10 · 9:31 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $449K
5,000 sh across 2 lots
Exec Dec 8 2025
Filed Dec 8 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $296K
5,000 sh × $59.19
Exec Oct 13 2025
Filed Oct 14 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. View filing → $311K
6,349 sh × $49.00
Exec Jun 3 2025
Filed Jun 3 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $439K
4,350 sh × $101.02
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $658K
7,500 sh across 2 lots
Exec Mar 12 2025
Filed Mar 14 2025 · 5:30 PM ET BPMCSALE Blueprint Medicines Corp View filing → $512K
5,766 sh × $88.80
Exec Mar 5 2025
Filed Mar 17 2025 · 5:30 PM ET † BPMCSALE Blueprint Medicines Corp View filing → $1.6M
14,961 sh across 2 lots
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET More filings →